DZ Bank’s Myovant Sciences Ltd. MYOV Stock Holding History

DZ Bank’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-21,599	Closed	-$459K	–	1129
2018 Q1	$459K	Buy	+21,599	New	+$329K	﹤0.01%	807

Other funds holding MYOV

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DZ Bank's MYOV Position: Q2 2018 in Review

DZ Bank sold out of Myovant Sciences Ltd. (MYOV) in Q2 2018, closing a stake of 21,599 shares — an estimated $459K sold.

DZ Bank first reported a position in MYOV in Q1 2018 and held it in 1 quarter. The position peaked at $459K in Q1 2018. 31 funds tracked by Wall St. Rank hold MYOV as of Q2 2018.

DZ Bank reported no remaining Myovant Sciences Ltd. position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 21,599 Myovant Sciences Ltd. shares in Q2 2018, an estimated $459K.
DZ Bank first reported a position in Myovant Sciences Ltd. in Q1 2018 and held it in 1 quarter.
DZ Bank's Myovant Sciences Ltd. position peaked at $459K in Q1 2018.
31 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.